Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q3 2023 Earnings

8NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-1.33

-1.13

-0.93

-0.73

Details

Expected EPS

-0.91

Actual EPS

-0.73

Surprise EPS

0.18

Surprise Percent

+19.78%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.73 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.